Comparative efficacy of GLP-1 RA, tirzepatide and SGLT-2 inhibitors in metabolic liver disease: A network meta-analysis - PubMed
5 days ago
- #NAFLD
- #SGLT-2 inhibitors
- #GLP-1 RA
- The study compares the efficacy of GLP-1 RAs, tirzepatide, and SGLT-2 inhibitors in treating metabolic liver diseases like NAFLD and NASH.
- Exenatide and tirzepatide showed significant reductions in liver fat fraction and enzymes, outperforming other treatments like liraglutide and dapagliflozin.
- The network meta-analysis included 25 studies with 2688 participants, highlighting the effectiveness of these drugs in improving NAFLD markers.